Suppr超能文献

随机临床试验设计是否适用于人群健康干预研究?

Is randomized trial design adapted to population health intervention research?

机构信息

Institut national de la santé et de la recherche médicale (Inserm) U1246, Tours, France.

Institut national de la santé et de la recherche médicale (Inserm) 1123, Paris, France.

出版信息

Glob Health Promot. 2021 Mar;28(1_suppl):86-88. doi: 10.1177/1757975920984727.

Abstract

Randomized trials are frequently used in clinical research and considered the gold standard, but they are less common in population health intervention research (PHIR). We discuss issues that are sometimes shared and sometimes distinct between PHIR and clinical research, notably the randomization unit, design, standardization of the intervention, outcome(s) and ethical issues. In the end, both PHIR and clinical research share the common aim of assessing interventions, and randomized trials should be more widely used in PHIR, provided that how they are planned and conducted is adapted to the PHIR context.

摘要

随机对照试验常用于临床研究,被视为金标准,但在人群健康干预研究(PHIR)中则较为少见。我们讨论了 PHIR 和临床研究之间有时共同、有时不同的问题,特别是随机分组单位、设计、干预标准化、结局和伦理问题。最后,PHIR 和临床研究都有评估干预措施的共同目标,只要随机试验的计划和实施适应 PHIR 背景,就应该更广泛地应用于 PHIR。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验